Document:

Exhibit 10.6

 

EXECUTION VERSION

 

BISON
CAPITAL ACQUISITION CORP. 

609-610
21st Century Tower

No.
40 Liangmaqiao Road

Chaoyang
District, Beijing, China

 

December
20, 2016

 

James
Jiayuan Tong

2073
Maple Avenue,

Costa
Mesa, California 92627

 

RE:     Securities
Purchase Agreement

 

Ladies
and Gentlemen:

 

We
are pleased to accept the offer you (the “Subscriber”) have made to purchase 373,000 ordinary shares (the “Shares”)
of no par value per share (the “Ordinary Shares”) in ourselves, Bison Capital Acquisition Corp.,
a British Virgin Islands company (the “Company”), up to 48,000 of which Shares shall be subject to complete or partial
forfeiture (the “Forfeiture”) by you if the underwriters of the initial
public offering (“IPO”) of the Company do not exercise or do not fully exercise their over-allotment option
(the “Over-allotment Option”) . The terms on which the Company is willing to sell the Shares to the Subscriber
pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and the Company
and the Subscriber’s agreements regarding such Shares, are as follows:

 

1.       Purchase
of Shares. For the aggregate sum of $6,487.00, which the Company acknowledges having already received in cash, the Company
hereby sells and issues to the Subscriber, and the Subscriber hereby purchases from the Company the Shares, for a purchase price
of approximately $0.0174 per Share, on the terms and subject to the conditions set forth in this agreement (this “Agreement”).
Concurrently with the Subscriber’s execution of this Agreement, the Company is delivering to the Subscriber certificate(s)
registered in the Subscriber’s name representing the Shares, receipt of which the Subscriber hereby acknowledges.

 

2.       Representations,
Warranties and Agreements.

 

2.1.       Subscriber’s
Representations, Warranties and Agreements. To induce the Company to issue the Shares to the Subscriber, the Subscriber hereby
represents and warrants to the Company and agrees with the Company as follows:

 

2.1.1.       No
Government Recommendation or Approval. The Subscriber understands that no United States federal or state agency or similar
agency of any other country has passed upon or made any recommendation or endorsement of the offering of the Shares.

 

2.1.2.       No
Conflicts. The execution, delivery and performance of this Agreement and the consummation by the Subscriber of the transactions
contemplated hereby do not violate, conflict with or constitute a default under (i) the provisions of the organizational documents
of such Subscriber, if any, (ii) any agreement, indenture or instrument to which such Subscriber is a party, or (iii) any law,
statute, rule or regulation to which the Subscriber is subject, or any agreement, order, judgment or decree to which such Subscriber
is subject.

 

2.1.3.       Organization
and Authority. Upon execution and delivery by the Subscriber, this Agreement is a legal, valid and binding agreement of such
Subscriber, enforceable against such Subscriber in accordance with its terms, except as such enforceability may be limited by
applicable bankruptcy, insolvency, fraudulent conveyance or similar laws affecting the enforcement of creditors’ rights
generally and subject to general principles of equity (regardless of whether enforcement is sought in a proceeding at law or in
equity).

 

    	 	1	 

     

    

 

2.1.4.       Experience,
Financial Capability and Suitability. Each Subscriber is: (i) sophisticated in financial matters and is able to evaluate the
risks and benefits of the investment in the Shares and (ii) able to bear the economic risk of his or her investment in the Shares
for an indefinite period of time because the Shares have not been registered under the Securities Act of 1933 and therefore cannot
be sold unless subsequently registered under the Securities Act or an exemption from such registration is available. The Subscriber
has substantial experience in evaluating and investing in transactions of securities in companies similar to the Company so that
he or she is capable of evaluating the merits and risks of his or her investment in the Company and has the capacity to protect
his or her own interests. The Subscriber must bear the economic risk of this investment until the Shares are sold pursuant to:
(i) an effective registration statement under the Securities Act or (ii) an exemption from registration available with respect
to such sale. The Subscriber is able to bear the economic risks of an investment in the Shares and to afford a complete loss of
Subscriber’s investment in the Shares.

 

2.1.5.       Access
to Information; Independent Investigation. Prior to the execution of this Agreement, the Subscriber has had the opportunity
to ask questions of and receive answers from representatives of the Company concerning an investment in the Company, as well as
the finances, operations, business and prospects of the Company, and the opportunity to obtain additional information to verify
the accuracy of all information so obtained. In determining whether to make this investment, Subscriber has relied solely on Subscriber’s
own knowledge and understanding of the Company and its business based upon Subscriber’s own due diligence investigation
and the information furnished pursuant to this paragraph. Subscriber understands that no person has been authorized to give any
information or to make any representations which were not furnished pursuant to this Section 2 and Subscriber has not relied on
any other representations or information in making its investment decision, whether written or oral, relating to the Company,
its operations and/or its prospects.

 

2.1.6.       Private
Offering. The Subscriber represents that he or she is an “accredited investor” as such term is defined in Rule
501(a) of Regulation D under the Securities Act and acknowledges the sale contemplated hereby is being made in reliance on a private
placement exemption pursuant to Section 4(a)(2) of the Securities Act and Regulation
D promulgated thereunder.

 

2.1.7.       Investment
Purposes. The Subscriber is purchasing the Shares solely for investment purposes, for the Subscriber’s own account and
not for the account or benefit of any other person, and not with a view towards the distribution or dissemination thereof and
the Subscriber has no present arrangement to sell the interest in the Shares to or through any person or entity. The Subscriber
did not decide to enter into this Agreement as a result of any general solicitation or general advertising within the meaning
of Rule 502 under the Securities Act.

 

2.1.8.       Restrictions
on Transfer; Shell Company; Affiliate Status. The Subscriber understands the Shares are being offered in a transaction not
involving a public offering within the meaning of the Securities Act. Subscriber understands the Shares will be “restricted
securities” within the meaning of Rule 144(a)(3) under the Securities Act and Subscriber understands that the certificates
representing the Shares will contain a legend in respect of such restrictions. If in the future the Subscriber decides to offer,
resell, pledge or otherwise transfer the Shares, such Shares may be offered, resold, pledged or otherwise transferred only pursuant
to: (i) registration under the Securities Act, or (ii) an available exemption from registration. Subscriber agrees that if any
transfer of its Shares or any interest therein is proposed to be made, as a condition precedent to any such transfer, Subscriber
may be required to deliver to the Company an opinion of counsel satisfactory to the Company. Absent registration or an exemption,
the Subscriber agrees not to resell the Shares. The Subscriber further acknowledges that because the Company is a shell company,
Rule 144 may not be available to the Subscriber for the resale of the Shares until one year following consummation of the initial
business combination of the Company, despite technical compliance with the requirements of Rule 144 and the release or waiver
of any contractual transfer restrictions. Such Subscriber (a) acknowledges that after the issuance of the Shares, such Subscriber
may be deemed an “affiliate” of the Company under the Securities Act, (b) acknowledges understanding the additional
restrictions under the Securities Act applicable to affiliate of the Company, and (c) acknowledges that it had a full and fair
opportunity and the means to obtain United States securities counsel and discuss such restrictions prior to entering into this
Agreement.

 

    	 	2	 

     

    

 

2.1.9.        No
Governmental Consents. No governmental, administrative or other third party consents or approvals are required, necessary
or appropriate on the part of Subscriber in connection with the transactions contemplated by this Agreement.

 

2.1.10.       Trading
Activities. In the event that the Ordinary Shares are listed on a stock exchange, the Subscriber’s trading activities,
if any, with respect to the Shares will be in compliance with all applicable state and federal securities laws, rules and regulations,
and the rules and regulations of such stock exchange.

 

2.1.11.       Bad
Actor. Such Subscriber is not subject to any of the “Bad Actor” disqualifications described in Rule 506(d)(1)(i)
to (viii) under the Securities Act (a “Disqualification Event”), except for a Disqualification Event covered
by Rule 506(d)(2) or (d)(3) under the Securities Act. The Subscriber has exercised reasonable care to determine whether he, she
or it is subject to a Disqualification Event. The purchase of the Shares will not subject the Company to any Disqualification
Event. There are no matters that would have triggered disqualification under Rule 506(d)(1) under the Securities Act but occurred
before September 23, 2013.

 

2.1.12.       No
Legal Advice from Company. The Subscriber acknowledges that it has had the opportunity to review this Agreement and the transactions
contemplated by this Agreement and the other agreements entered into between the parties hereto with its own legal counsel and
investment and tax advisors. Except for any statements or representations of the Company made in this Agreement and the other
agreements entered into between the parties hereto, the Subscriber is relying solely on such counsel and advisors and not on any
statements or representations of the Company or any of its representatives or agents for legal, tax or investment advice with
respect to this investment, the transactions contemplated by this Agreement or the securities laws of any jurisdiction.

 

2.1.13.      
Reliance on Representations and Warranties. The Subscriber understands the Shares are being offered and sold to it in reliance
on exemptions from the registration requirements under the Securities Act, and analogous provisions in the laws and regulations
of various states, and that the Company is relying upon the truth and accuracy of the representations, warranties, agreements,
acknowledgments and understandings of the Subscriber set forth in this Agreement in order to determine the applicability of such
provisions.

 

2.1.14.       No
General Solicitation or General Advertising; No Directed Selling Efforts. The Subscriber is not aware of any form of general
solicitation or general advertising (within the meaning of Regulation D) in respect of the Shares, including (1) any advertisement,
article, notice or other communication published in any newspaper, magazine, or similar media or broadcast over television, radio,
or the internet; and (2) any seminar or meeting whose attendees have been invited by any general solicitation or general advertising.

 

2.2.       Company’s
Representations, Warranties and Agreements. To induce the Subscriber to purchase the Shares, the Company hereby represents
and warrants to the Subscriber and agrees with the Subscriber as follows:

 

2.2.1.       Organization
and Corporate Power. The Company is a corporation duly incorporated, validly existing and in good standing under the laws
of the British Virgin Islands and is qualified to do business in every jurisdiction in which the failure to so qualify would reasonably
be expected to have a material adverse effect on the financial condition, operating results or assets of the Company. The Company
possesses all requisite corporate power and authority necessary to carry out the transactions contemplated by this Agreement.

 

2.2.2.       No
Conflicts. The execution, delivery and performance of this Agreement and the consummation by the Company of the transactions
contemplated hereby do not violate, conflict with or constitute a default under (1) the memorandum and articles of association
of the Company, (2) any agreement, indenture or instrument to which the Company is a party, or (3) any law, statute, rule
or regulation to which the Company is subject, or any agreement, order, judgment or decree to which the Company is subject. Other
than any federal, state or foreign securities filings which may be required to be made by the Company subsequent to the IPO, and
any registration statement which may be filed pursuant thereto, the Company is not required under federal, state or local law,
rule or regulation to obtain any consent, authorization or order of, or make any filing or registration with, any court or governmental
agency or self-regulatory entity in order for it to perform any of its obligations under this Agreement or issue the Shares in
accordance with the terms hereof.

 

    	 	3	 

     

    

 

2.2.3.       Title
to Securities. Upon issuance in accordance with, and payment pursuant to, the terms hereof, the Shares will be duly and validly
issued, fully paid and nonassessable. Upon issuance in accordance with, and payment pursuant to, the terms hereof the Subscriber
will have or receive good title to the Shares, free and clear of all liens, claims and encumbrances of any kind, other than (i)
transfer restrictions hereunder and under the other agreements contemplated hereby, (ii) transfer restrictions under federal and
state securities laws, and (iii) liens, claims or encumbrances imposed due to the action of the Subscriber.

 

2.2.4.       Enforcement.
This Agreement constitutes, and upon the execution and delivery thereof, valid and binding obligations of the Company enforceable
against the Company in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency,
fraudulent conveyance, moratorium, reorganization, or similar laws relating to, or affecting generally the enforcement of, creditors’
rights and remedies or by equitable principles of general application and except as enforcement of rights to indemnity and contribution
may be limited by federal and state securities laws or principles of public policy.

 

2.2.5.       No
Registration. Assuming the accuracy of the representations and warranties of the Subscriber contained in this Agreement, the
issuance and sale of the Shares pursuant to this Agreement is exempt from registration requirements of the Securities Act, and
neither the Company nor, to the knowledge of the Company, any authorized representative acting on its behalf, has taken or will
take any action hereafter that would cause the loss of such exemption.

 

2.2.6.       No
Integration. Neither the Company nor any of its affiliates have, directly or indirectly through any agent, sold, offered for
sale, solicited offers to buy or otherwise negotiated in respect of, any “security” (as defined in the Securities
Act) that is or will be integrated with the sale of the Shares in a manner that would require registration under the Securities
Act.

 

2.2.7.       No
General Solicitation or General Advertising. Neither the Company nor any person acting on behalf of the Company has offered
or sold any of the Shares by any form of general solicitation or general advertising (within the meaning of Regulation D promulgated
under the Securities Act) including (1) any advertisement, article, notice or other communication published in any newspaper,
magazine, or similar media or broadcast over television, radio, or the internet; and (2) any seminar or meeting whose attendees
have been invited by any general solicitation or general advertising; nor has it seen or been aware of any activity that, to its
knowledge, constitutes general solicitation or general advertising.

 

3.       Forfeiture
of Shares.

 

3.1.       Partial
or No Exercise of the Over-allotment Option. In the event the Over-allotment Option is not exercised in full, the Subscriber
shall forfeit any and all rights to up to 48,000 Shares (based upon the percentage of the Over-allotment Option not exercised)
such that immediately following such Forfeiture, the Subscriber and all other initial shareholders prior to the IPO will own an
aggregate number of Ordinary Shares (not including Ordinary Shares or Ordinary Shares issuable upon exercise of any warrants in
each case purchased by the Subscriber and the other initial shareholders in the Company’s pre-IPO placements or IPO or in
the aftermarket) equal to 20% of the issued and outstanding Ordinary Shares of the Company immediately following the IPO. The
amount of Ordinary Shares to be forfeited shall be pro rata among the Subscriber and the other initial shareholders subject to
forfeiture on the basis of the total number of Ordinary Shares held by each of the Subscriber and each other initial shareholders
subject to forfeiture (not including Ordinary Shares or Ordinary Shares issuable upon exercise of any warrants in each case purchased
by the Subscriber and the other initial shareholders in the Company’s pre-IPO placements or IPO or in the aftermarket).

 

    	 	4	 

     

    

 

3.2.       Termination
of Rights as Shareholder. If any of the Shares are forfeited by the Subscriber in accordance with this Section 3, then after
such time, the Subscriber (or successor in interest), shall no longer have any rights as a holder of such Shares, and the Company
shall take such action as is appropriate to cancel such Shares which may include by way of the compulsory redemption or surrender
and cancellation of such Shares for nil consideration. In addition, the Subscriber hereby irrevocably grants the Company a limited
power of attorney for the purpose of effectuating the foregoing and agrees to take any and all action reasonably requested by
the Company necessary to effect any adjustment in this Section 3 (including any such redemption as is referred to herein above).

 

4.       Waiver
of Liquidation Distributions; Redemption Rights. In connection with the Shares purchased pursuant to this Agreement and, subject
to the below, any other Company securities purchased on a private placement basis, the Subscriber hereby waives any and all right,
title, interest or claim of any kind in or to any distributions by the Company from the Trust Account (as such term is defined
in the Investment Management Trust Agreement to be entered by and between the Company and the trustee thereunder), in the event
of a liquidation of the Company upon the Company’s failure to timely complete a business combination. For purposes of clarity,
in the event any Subscriber purchases Ordinary Shares in the IPO or in the aftermarket, any additional shares so purchased shall
be eligible to receive their pro rata portion of any liquidating distributions by the Company. However, in no event will the Subscriber
have the right to redeem any Shares, or any other Company securities purchased on a private placement basis, or any Ordinary Shares
purchased in the IPO or in the aftermarket, for funds held in the Trust Account upon the successful completion of a business combination.

 

5.       Restrictions
on Transfer.

 

5.1.       Securities
Law Restrictions. In addition to any restrictions to be contained in the Share Escrow Agreement (as defined in Section 5.4
below), the Subscriber agrees not to sell, transfer, pledge, hypothecate or otherwise dispose of all or any part of the Shares
unless, prior thereto (i) a registration statement on the appropriate form under the Securities Act and applicable state securities
laws with respect to the Shares proposed to be transferred shall then be effective, or (ii) that an exemption from registration
is available under the Securities Act and the rules promulgated by the Commission thereunder and is in compliance with all applicable
state securities laws.

 

5.2.       Restrictive
Legends. Unless counsel otherwise advises, all certificates representing the Shares shall have endorsed thereon legends substantially
as follows:

 

“THE
SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”),
OR ANY STATE SECURITIES LAWS AND NEITHER THE SECURITIES NOR ANY INTEREST THEREIN MAY BE OFFERED, SOLD, TRANSFERRED, PLEDGED OR
OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN EXEMPTION
FROM REGISTRATION THEREUNDER, IN EACH CASE IN ACCORDANCE WITH ALL APPLICABLE SECURITIES LAWS OF THE STATES OR OTHER JURISDICTIONS,
AND IN THE CASE OF A TRANSACTION EXEMPT FROM REGISTRATION, SUCH SECURITIES MAY ONLY BE TRANSFERRED IF THE COMPANY AND TRANSFER
AGENT FOR SUCH SECURITIES HAS RECEIVED DOCUMENTATION SATISFACTORY TO IT THAT SUCH TRANSACTION DOES NOT REQUIRE REGISTRATION UNDER
THE SECURITIES ACT.”

 

“THE
SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A SHARE ESCROW AGREEMENT AND MAY NOT BE OFFERED, SOLD, TRANSFERRED,
PLEDGED OR OTHERWISE DISPOSED DURING THE TERM OF THE SHARE ESCROW AGREEMENT, EXCEPT IN ACCORDANCE WITH THE TERMS THEREOF.”

 

    	 	5	 

     

    

 

5.3.       Additional
Shares or Substituted Securities. In the event of the declaration of a stock dividend, the declaration of an extraordinary
dividend payable in a form other than stock, a spin-off, a stock split, an adjustment in conversion ratio, a recapitalization
or a similar transaction affecting the Company’s outstanding capital stock without receipt of consideration, any new, substituted
or additional securities or other property which are by reason of such transaction distributed with respect to any Shares subject
to this Section 5 or into which such Shares thereby become convertible shall immediately be subject to this Section 5. Appropriate
adjustments to reflect the distribution of such securities or property shall be made to the number and/or class of Shares subject
to this Section 5.

 

5.4.       Lock-up.
The Subscriber acknowledges that the Shares will be subject to lock-up provisions (the “Lock-up”) contained
in the Share Escrow Agreement to be entered into by and among the Company, the Subscriber and an escrow agent acceptable to the
Company (the “Share Escrow Agreement”). Pursuant to the Share Escrow Agreement, the Subscriber shall not sell,
transfer, pledge, hypothecate or otherwise dispose 50% or more of his or her respective Shares until the earlier of one year after
the date of the consummation of the Company’s initial business combination (the “Consummation Date”)
and the date on which the closing price of the Ordinary Shares equals or exceeds $12.50 per share (as adjusted for stock splits,
stock dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing following
the Consummation Date, subject to certain exceptions set forth in the Share Escrow Agreement. In addition, the Subscriber shall
not sell, transfer, pledge, hypothecate or otherwise dispose of any or all of the remaining 50% of the Shares until one year after
the Consummation Date, subject to certain exceptions set forth in the Share Escrow Agreement.

 

5.5.       Registration
Rights. The Subscriber acknowledges that the Shares are being purchased pursuant to an exemption from the registration requirements
of the Securities Act and will become freely tradable only after they are registered pursuant to a Registration Rights Agreement
to be entered into with the Company prior to the closing of the IPO (the “Registration Rights Agreement”) (subject
to any restriction set forth in Section 5.4 above). The Subscriber is entitled to make such number of demands that the Company
registers the Shares pursuant to the terms and restrictions as set forth in the Registration Rights Agreement.

 

6.       Other
Agreements.

 

6.1.       Further
Assurances. The Subscriber agrees to execute such further instruments and to take such further action as may reasonably be
necessary to carry out the intent of this Agreement.

 

6.2.       No
Obligation as to Employment. The Company is not by reason of this Agreement obligated to employ, or continue to employ, the
Subscriber in any capacity.

 

6.3.       Notices.
All notices, requests, consents and other communications hereunder shall be in writing, shall be addressed to the receiving party’s
address set forth on the first page of this Agreement or to such other address as a party may designate by notice hereunder, and
shall be either (1) delivered by hand, (2) sent by overnight courier, (3) sent via facsimile, or (4) sent by certified mail, return
receipt requested, postage prepaid. All notices, requests, consents and other communications hereunder shall be deemed to have
been given either (i) if by hand, at the time of the delivery thereof to the receiving party at the address of such party set
forth above, (ii) if sent by overnight courier, on the next business day following the day such notice is delivered to the courier
service, (iii) if sent via facsimile, when receipt is acknowledged, or (iv) if sent by certified mail, on the (5th)
business day following the day such mailing is made.

 

6.4.       Entire
Agreement. This Agreement, together with the Share Escrow Agreement and the Letter Agreement between the Subscriber and the
Company, to be entered into prior to the date of the preliminary prospectus in connection with the IPO, substantially in the form
to be filed as an exhibit to the Company’s registration statement on Form S-1, embodies the entire agreement and understanding
between the Subscriber and the Company with respect to the subject matter hereof and supersedes all prior oral or written agreements
and understandings relating to the subject matter hereof. No statement, representation, warranty, covenant or agreement of any
kind not expressly set forth in this Agreement shall affect, or be used to interpret, change or restrict, the express terms and
provisions of this Agreement.

 

    	 	6	 

     

    

 

6.5.       Modifications
and Amendments. The terms and provisions of this Agreement may be modified or amended only by written agreement executed by
all parties hereto.

 

6.6.       Waivers
and Consents. The terms and provisions of this Agreement may be waived, or consent for the departure therefrom granted, only
by written document executed by the party entitled to the benefits of such terms or provisions. No such waiver or consent shall
be deemed to be or shall constitute a waiver or consent with respect to any other terms or provisions of this Agreement, whether
or not similar. Each such waiver or consent shall be effective only in the specific instance and for the purpose for which it
was given, and shall not constitute a continuing waiver or consent.

 

6.7.       Assignment.
The rights and obligations under this Agreement may not be assigned by either party hereto without the prior written consent of
the other party.

 

6.8.       Benefit.
All statements, representations, warranties, covenants and agreements in this Agreement shall be binding on the parties hereto
and shall inure to the benefit of the respective successors and permitted assigns of each party hereto. Nothing in this Agreement
shall be construed to create any rights or obligations except among the parties hereto, and no person or entity shall be regarded
as a third-party beneficiary of this Agreement.

 

6.9.       Governing
Law. This Agreement and the rights and obligations of the parties hereunder shall be construed in accordance with and governed
by the laws of the British Virgin Islands for agreements made and to be wholly performed within such country.

 

6.10.     Severability.
In the event that any court of competent jurisdiction shall determine that any provision, or any portion thereof, contained in
this Agreement shall be unreasonable or unenforceable in any respect, then such provision shall be deemed limited to the extent
that such court deems it reasonable and enforceable, and as so limited shall remain in full force and effect. In the event that
such court shall deem any such provision, or portion thereof, wholly unenforceable, the remaining provisions of this Agreement
shall nevertheless remain in full force and effect.

 

6.11.      No
Waiver of Rights, Powers and Remedies. No failure or delay by a party hereto in exercising any right, power or remedy under
this Agreement, and no course of dealing between the parties hereto, shall operate as a waiver of any such right, power or remedy
of such party. No single or partial exercise of any right, power or remedy under this Agreement by a party hereto, nor any abandonment
or discontinuance of steps to enforce any such right, power or remedy, shall preclude such party from any other or further exercise
thereof or the exercise of any other right, power or remedy hereunder. The election of any remedy by a party hereto shall not
constitute a waiver of the right of such party to pursue other available remedies. No notice to or demand on a party not expressly
required under this Agreement shall entitle the party receiving such notice or demand to any other or further notice or demand
in similar or other circumstances or constitute a waiver of the rights of the party giving such notice or demand to any other
or further action in any circumstances without such notice or demand.

 

6.12.       Survival
of Representations and Warranties. All representations and warranties made by the parties hereto in this Agreement or in any
other agreement, certificate or instrument provided for or contemplated hereby, shall survive the execution and delivery hereof
and any investigations made by or on behalf of the parties.

 

6.13.       No
Broker or Finder. Each of the parties hereto represents and warrants to the other that no broker, finder or other financial
consultant has acted on its behalf in connection with this Agreement or the transactions contemplated hereby in such a way as
to create any liability on the other. Each of the parties hereto agrees to indemnify and save the other harmless from any claim
or demand for commission or other compensation by any broker, finder, financial consultant or similar agent claiming to have been
employed by or on behalf of such party and to bear the cost of legal expenses incurred in defending against any such claim.

 

    	 	7	 

     

    

 

6.14.       Headings
and Captions. The headings and captions of the various subdivisions of this Agreement are for convenience of reference only
and shall in no way modify or affect the meaning or construction of any of the terms or provisions hereof.

 

6.15.       Counterparts.
This Agreement may be executed in one or more counterparts, all of which when taken together shall be considered one and the same
agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being
understood that both parties need not sign the same counterpart.  In the event that any signature is delivered by facsimile
transmission or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation
of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or
“.pdf” signature page were an original thereof.

 

7.       Voting
and Tender of Shares. The Subscriber agrees to vote the Shares as well as any Ordinary Shares acquired in the IPO or the aftermarket
in favor of a business combination that the Company negotiates and presents for approval to the Company’s shareholders and
shall not seek redemption with respect to the Shares. Additionally, the Subscriber agrees not to tender any Share in connection
with a tender offer presented to the Company’s shareholders in connection with an initial business combination negotiated
by the Company.

 

8.       Indemnification.
Each party shall indemnify the other and the underwriter of the IPO against any loss, cost or damages (including reasonable attorney’s
fees and expenses) incurred as a result of such party’s breach of any representation, warranty, covenant or agreement in
this Agreement.

 

9.       Disclosure.
The Subscriber agrees not to disclose information about this Agreement and the transactions contemplated hereby until and to the
extent the Company publicly discloses such information.

 

10.     Fees.
Each party hereto shall be responsible for its own internal costs and legal, accounting and other professional fees incurred in
connection with the negotiation, preparation and execution of this Agreement.

 

[Signature
Page Follows]

 

    	 	8	 

     

    

 

If
the foregoing accurately sets forth our understanding and agreement, please sign the enclosed copy of this agreement and return
it to us.

 

Accepted
and agreed this

December
20, 2016

 

	 	Very
    truly yours,
	 	 
	 	BISON
    CAPITAL ACQUISITION CORP.
	 	 	 
	 	By:	/s/
    James Jiayuan Tong
	 	Name: 	James
    Jiayuan Tong
	 	Title:	Chief
    Executive Officer, Chief Financial Officer and Director

  

[Signature
Page to Insider Shares Purchase Agreement-the Company]

 

     

     

    

 

Accepted
and agreed to this

December
20, 2016

 

	By:	/s/
    James Jiayuan Tong	 
	Name: 	James
    Jiayuan Tong	 

 

 

[Signature
Page to Insider Shares Purchase Agreement-James Jiayuan Tong]Exhibit 10.7

 

EXECUTION VERSION

 

UNIT
SUBSCRIPTION AGREEMENT

 

This
UNIT SUBSCRIPTION AGREEMENT (this “Agreement”) is made as of this 20th day of December, 2016,
by and between Bison Capital Acquisition Corp., a British Virgin Islands business company (the “Company”),
having its principal place of business at 609-610 21st Century Tower, No. 40 Liangmaqiao Road, Chaoyang District, Beijing,
China, and Bison Capital Holding Company Limited, a Cayman Island company, having its principal place of business at 609-610 21st
Century Tower, No. 40 Liangmaqiao Road, Chaoyang District, Beijing, China (the “Purchaser”).

 

WHEREAS,
subject to the terms and conditions set forth in this Agreement and pursuant to Section
4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), Rule 506 of Regulation D (“Regulation
D”) under the Securities Act and/or Regulation S (“Regulation
S”) under the Securities Act, the Company desires to sell in a private
placement (the “Offering”) up to an aggregate of 272,500 units (the “Units”) of the Company,
each Unit comprised of one ordinary share of the Company, no par value per share (collectively, the “Ordinary Shares”),
and one warrant (the collectively, the “Warrants”) to purchase one Ordinary Share (collectively, the “Warrant
Shares”), to be governed by the Warrant Agreement (defined herein), on the consummation of an acquisition, share exchange,
purchase of all or substantially all of the assets of, or any other similar business combination with one or more businesses or
entities (a “Business Combination”), for an aggregate purchase price of up to $2,725,000, or $10.00 per Unit.

 

WHEREAS,
the Purchaser desires to purchase the Units and the Company wishes to accept such subscription on the terms herein.

 

NOW,
THEREFORE, in consideration of the premises and the mutual covenants hereinafter set forth and other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the Company and the Purchaser hereby agree as follows:

 

1.            Purchase and Issuance of the Units.

 

For
the aggregate sum of $2,500,000 (the “Initial Purchase Price”), upon the terms and subject to the conditions
of this Agreement, the Purchaser hereby agrees to purchase from the Company, and the Company hereby agrees to sell to the Purchaser,
on the Closing Date (as defined in Section 1.2) 250,000 Units (the “Initial Units”) at $10.00 per Initial Unit.

 

In
addition to the foregoing, the Purchaser hereby conditionally agrees to purchase up to an additional 22,500 Units (collectively,
the “Additional Units”) at $10.00 per Additional Unit for a purchase price of $225,000 (the “Additional
Purchase Price” and together with the Initial Purchase Price, the “Purchase Price”), if, and only
if, and only to the extent that the underwriters’ 30-day over-allotment option (the “Over-Allotment Option”)
in the IPO (as defined below) is exercised in full or part. The total number of Additional Units to be purchased hereunder shall
be the number that is necessary to maintain in the Trust Account (as defined below) an amount equal to $10.00 per Ordinary Share
sold to the public in the IPO. Each purchase of Additional Units shall occur simultaneously with the consummation of any portion
of the Over-Allotment Option.

 

1.1.            Closing.
The closing (the “Closing”) of the Offering shall take place at the offices of Watson Farley & Williams
LLP, 250 West 55th Street, New York, New York, 10019 simultaneously with the consummation of the Company’s initial
public offering (“IPO”) of 5,000,000 units consisting of Ordinary Shares and warrants and the consummation
of the exercise of all or any portion of the Over-Allotment Option (each a “Closing Date”).

 

    	 	1	 

     

    

 

1.2.            Delivery
of the Purchase Price. At least one business day prior to the effective date of the Company’s registration statement
relating to the IPO (the “Registration Statement”), or the date of the exercise of the Over-Allotment Option,
if any, the Purchaser agrees to deliver the Initial Purchase Price or Additional Purchase Price, as the case may be, by certified
bank check or wire transfer of immediately available funds denominated in United States Dollars to Continental Stock Transfer
& Trust Company or any other agent designated by the Company which is hereby irrevocably authorized to deposit such funds
on the applicable Closing Date to the trust account which will be established for the benefit of the Company’s public shareholders,
managed pursuant to that certain investment management trust agreement to be entered into by and between the Company and a trustee
and into which substantially all of the net proceeds of the IPO (less than certain amount of fund not held in the trust account)
will be deposited (the “Trust Account”). If the IPO is not consummated within 14 days of the date the Initial
Purchase Price is delivered to Continental Stock Transfer & Trust Company or any other agent designated by the Company, the
Initial Purchase Price shall be returned to the Purchaser by certified bank check or wire transfer of immediately available funds
denominated in United States Dollars, without interest or deduction.

 

1.3.            Delivery
of Unit Certificate. Upon the applicable Closing Date after delivery of the Purchase Price in accordance with Section 1.3,
the Purchaser shall become irrevocably entitled to receive a unit certificate representing the Units purchased hereunder. 

 

2.            Representations and Warranties of the Purchasers

 

The
Purchaser represents and warrants to the Company that:

 

2.1.            No
Government Recommendation or Approval. The Purchaser understands that no United States federal or state agency or similar
agency of any other country has passed upon or made any recommendation or endorsement of the Company, the Offering, the Units,
the Warrants, or the Warrant Shares, or the Ordinary Shares underlying the Units (the “Unit Shares” and, collectively
with the Units, the Warrants and the Warrant Shares, the “Securities”).

 

2.2.            Organization.  The Purchaser is a company, validly existing and in good standing under the laws of its jurisdiction
and possesses all requisite power and authority necessary to carry out the transactions contemplated by this Agreement.

 

2.3.            Private Offering. The Purchaser is an “accredited investor” as such term is defined in Rule 501(a) of Regulation
D (the “Securities Act”) and it is not a “U.S. person” as defined in Rule 902 of Regulation S.
The Purchaser acknowledges that the sale contemplated hereby is being made in reliance on a private placement exemption pursuant
to Section 4(a)(2) of the Securities Act, Regulation D and/or Regulation S promulgated
thereunder.

 

2.4.            Authority.
This Agreement has been validly authorized, executed and delivered by the Purchaser and is a valid and binding agreement enforceable
in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, fraudulent conveyance
or similar laws affecting the enforcement of creditors’ rights generally and subject to general principles of equity (regardless
of whether enforcement is sought in a proceeding at law or in equity).

 

2.5.            No Conflicts. The execution, delivery and performance of this Agreement and the consummation by the Purchaser of the transactions
contemplated hereby do not violate, conflict with or constitute a default under (i) the Purchaser’s organizational
documents, (ii) any agreement, indenture or instrument to which the Purchaser is a party or (iii) any law, statute, rule
or regulation to which the Purchaser is subject, or any agreement, order, judgment or decree to which the Purchaser is subject.

 

2.6.            No Legal Advice from Company. The Purchaser acknowledges that it has had the opportunity to review this Agreement and the
transactions contemplated by this Agreement and the other agreements entered into between the parties hereto with its own legal
counsel and investment and tax advisors. Except for any statements or representations of the Company made in this Agreement and
the other agreements entered into between the parties hereto, the Purchaser is relying solely on such counsel and advisors and
not on any statements or representations of the Company or any of its representatives or agents for legal, tax or investment advice
with respect to this investment, the transactions contemplated by this Agreement or the securities laws of any jurisdiction.

 

    	 	2	 

     

    

 

2.7.            Access to Information; Independent Investigation. Prior to the execution of this Agreement, the Purchaser has had the opportunity
to ask questions of and receive answers from representatives of the Company concerning an investment in the Company, as well as
the finances, operations, business and prospects of the Company, and the opportunity to obtain additional information to verify
the accuracy of all information so obtained. In determining whether to make this investment, the Purchaser has relied solely on
its own knowledge and understanding of the Company and its business based upon its own due diligence investigation and the information
furnished pursuant to this paragraph. The Purchaser understands that no person has been authorized to give any information or
to make any representations which were not furnished pursuant to this Section 2 and it has not relied on any other representations
or information in making its investment decision, whether written or oral, relating to the Company, its operations and/or its
prospects.

 

2.8.            Reliance on Representations and Warranties. The Purchaser understands the Units are being offered and sold to it in reliance
on exemptions from the registration requirements under the Securities Act, and analogous provisions in the laws and regulations
of various states, and that the Company is relying upon the truth and accuracy of the representations, warranties, agreements,
acknowledgments and understandings of the Purchaser set forth in this Agreement in order to determine the applicability of such
provisions.

 

2.9.            No General Solicitation or General Advertising; No Directed Selling Efforts. The Purchaser is not aware of any form of
general solicitation or general advertising (within the meaning of Regulation D) in respect of the Securities, including (1) any
advertisement, article, notice or other communication published in any newspaper, magazine, or similar media or broadcast over
television, radio, or the internet; and (2) any seminar or meeting whose attendees have been invited by any general solicitation
or general advertising. The Purchaser is not aware of any form of “directed selling efforts” (as defined in Regulation
S) in the United States in respect of the Securities, which would include any activities undertaken for the purpose of, or that
could reasonably be expected to have the effect of, conditioning the market in the United States for the resale of the Securities,
including placing an advertisement in a publication with a general circulation in the United States.

 

2.10.          Legend. The Purchaser acknowledges and agrees the certificates evidencing the Units, the Unit Shares, the Warrants, and
the Warrant Shares when issued, shall bear a restrictive legend (the “Legend”), in form and substance as set
forth in Section 4 hereof, prohibiting the offer, sale, pledge or transfer of the securities except (i) pursuant to
an effective registration statement covering these securities under the Securities Act or (ii) pursuant to any other exemptions
from the registration requirements under the Securities Act and the rules thereunder and with all applicable state securities
laws.

 

2.10.          Experience,
Financial Capability and Suitability. The Purchaser is (i) sophisticated in financial matters and is able to evaluate the
risks and benefits of the investment in the Securities and (ii) able to bear the economic risk of its investment in the Securities
for an indefinite period of time because the Securities have not been registered under the Securities Act and therefore cannot
be sold unless subsequently registered under the Securities Act or an exemption from such registration is available. It has substantial
experience in evaluating and investing in transactions of securities in companies similar to the Company so that it is capable
of evaluating the merits and risks of its investment in the Company and has the capacity to protect its own interests. The Purchaser
must bear the economic risk of this investment until the Securities are sold pursuant to: (i) an effective registration statement
under the Securities Act or (ii) an exemption from registration available with respect to such sale. The Purchaser is able to
bear the economic risks of an investment in the Securities and to afford a complete loss of the Purchaser’s investment in
the Securities.

 

2.11.          Investment
Purposes. The Purchaser is purchasing the Securities solely for investment purposes, for its own account and not for the account
or benefit of any other person, and not with a view towards the distribution or dissemination thereof and the Purchaser has no
present arrangement to sell the interest in the Securities to or through any person or entity.

 

    	 	3	 

     

    

 

2.12.          Restrictions on Transfer; Shell Company; Affiliate Status. The Purchaser acknowledges and understands the Units are being
offered in a transaction not involving a public offering in the United States within the meaning of the Securities Act. The Securities
have not been registered under the Securities Act, and, if in the future, the Purchaser decides to offer, resell, pledge or otherwise
transfer the Securities, such Securities may be offered, resold, pledged or otherwise transferred only (A) pursuant to an
effective registration statement filed under the Securities Act, (B) pursuant to an exemption from registration under Rule
144 promulgated under the Securities Act (the “Rule 144”), if available, or (C) pursuant to any other
available exemption from the registration requirements of the Securities Act, and in each case in accordance with any applicable
securities laws of any state or any other jurisdiction. The Purchaser agrees that if any transfer of its Securities or any interest
therein is proposed to be made, as a condition precedent to any such transfer, the Purchaser may be required to deliver to the
Company an opinion of counsel satisfactory to the Company. Absent registration or another available exemption from registration,
the Purchaser agrees it will not resell the Securities. It further acknowledges that because the Company is a shell company, Rule
144 may not be available to it for the resale of the Securities until the one year anniversary following consummation of the initial
Business Combination of the Company, despite technical compliance with the requirements of Rule 144 and the release or waiver
of any contractual transfer restrictions. Such Purchaser (a) acknowledges that after the issuance of the Securities, such Purchaser
may be deemed an “affiliate” of the Company under the Securities Act, (b) acknowledges understanding the additional
restrictions under the Securities Act applicable to affiliate of the Company, and (c) acknowledges that it had a full and fair
opportunity and the means to obtain United States securities counsel and discuss such restrictions prior to entering into this
Agreement.

 

2.13.          No Governmental Consents. No governmental, administrative or other third party consents or approvals are required, necessary
or appropriate on the part of the Purchaser in connection with the transactions contemplated by this Agreement.

 

2.14.          Trading Activities. In the event that the Securities are listed on a stock exchange, the Purchaser’s trading activities,
if any, with respect to the Shares will be in compliance with all applicable state and federal securities laws, rules and regulations,
and the rules and regulations of such stock exchange.

 

2.15.          Bad Actor The Purchaser is not subject to any of the “Bad Actor” disqualifications described in Rule 506(d)(1)(i)
to (viii) under the Securities Act (a “Disqualification Event”), except for a Disqualification Event covered
by Rule 506(d)(2) or (d)(3) under the Securities Act. The Purchaser has exercised reasonable care to determine whether he, she
or it is subject to a Disqualification Event. The Purchaser will not subject the Company to any Disqualification Event. There
are no matters that would have triggered disqualification under Rule 506(d)(1) under the Securities Act but occurred before September
23, 2013.

 

3.            Representations and Warranties of the Company

 

The
Company represents and warrants to the Purchasers that:

 

3.1.            Valid Issuance of Share Capital. The total number of all classes of share capital which the Company has authority to issue
is (i) an unlimited number of Ordinary Shares and (ii) an unlimited number of preferred shares. As of the date hereof, the Company
has issued 1,437,500 Ordinary Shares (of which 187,500 Ordinary Shares are subject to forfeiture as described in the Registration
Statement) and no preferred shares are issued and outstanding. All of the issued share capital of the Company has been duly authorized,
validly issued, and are fully paid and non-assessable.

 

3.2.            Title to Securities. Upon issuance in accordance with, and payment pursuant to, the terms hereof and a warrant agreement
to be entered into with a mutually agreeable warrant agent on or prior to the closing of the IPO (the “Warrant Agreement”),
each of the Units are issued, the Warrants and the Unit Shares will be duly and validly issued, fully paid and non-assessable.
When the Units are issued, the Warrant Shares will have been reserved for issuance. Upon issuance in accordance with the terms
of the Warrant Agreement, the Purchaser will have or receive good title to the Warrant Shares, free and clear of all liens, claims
and encumbrances of any kind, other than (i) transfer restrictions hereunder and under other agreements contemplated hereby, (ii)
transfer restrictions under federal and state securities laws and (iii) liens, claims or encumbrances imposed due to the action
of the Purchaser.

 

3.3.            Organization
and Qualification. The Company has been duly incorporated and is validly existing as a British Virgin Islands business company
and has the requisite corporate power to own its properties and assets and to carry on its business as now being conducted.

 

    	 	4	 

     

    

 

3.4.            Authorization; Enforcement. (i) The Company has the requisite corporate power and authority to enter into and perform
its obligations under this Agreement and to issue the Securities in accordance with the terms hereof, (ii) the execution,
delivery and performance of this Agreement by the Company and the consummation by it of the transactions contemplated hereby have
been duly authorized by all necessary corporate action and no further consent or authorization of the Company or its Board of
Directors or shareholders is required, and (iii) this Agreement constitutes, and upon the execution and delivery thereof,
the Warrants and Warrant Agreement will constitute valid and binding obligations of the Company enforceable against the Company
in accordance with their respective terms, except as such enforceability may be limited by applicable bankruptcy, insolvency,
fraudulent conveyance, moratorium, reorganization, or similar laws relating to, or affecting generally the enforcement of, creditors’
rights and remedies or by equitable principles of general application and except as enforcement of rights to indemnity and contribution
may be limited by federal and state securities laws or principles of public policy.

 

3.5.            No Conflicts. The execution, delivery and performance of this Agreement and the consummation by the Company of the transactions
contemplated hereby do not (i) result in a violation of the Company’s Memorandum and Articles of Association, (ii) conflict
with, or constitute a default under any agreement, indenture or instrument to which the Company is a party or (iii) conflict with
any law statute, rule or regulation to which the Company is subject or any agreement, order, judgment or decree to which the Company
is subject. Other than any federal, state or foreign securities filings which may be required to be made by the Company subsequent
to the Closing, and any registration statement which may be filed pursuant thereto, the Company is not required under federal,
state or local law, rule or regulation to obtain any consent, authorization or order of, or make any filing or registration with,
any court or governmental agency or self-regulatory entity in order for it to perform any of its obligations under this Agreement
or issue the Units, the Warrants, or the Unit Shares, or Warrant Shares in accordance with the terms hereof.

 

3.6.            No Registration. Assuming the accuracy of the representations and warranties of the Purchaser contained in this Agreement,
the issuance and sale of the Private Units pursuant to this Agreement is exempt from registration requirements of the Securities
Act, and neither the Company nor, to the knowledge of the Company, any authorized representative acting on its behalf, has taken
or will take any action hereafter that would cause the loss of such exemption.

 

3.7.            No Integration. Neither the Company nor any of its affiliates have, directly or indirectly through any agent, sold, offered
for sale, solicited offers to buy or otherwise negotiated in respect of, any “security” (as defined in the Securities
Act) that is or will be integrated with the sale of the Units in a manner that would require registration under the Securities
Act.

 

3.8.            No
General Solicitation or General Advertising; No Directed Selling Efforts. Neither
the Company nor any person acting on behalf of the Company has offered or sold any of the Securities by any form of general
solicitation or general advertising (within the meaning of Regulation D) including (1) any advertisement, article, notice or
other communication published in any newspaper, magazine, or similar media or broadcast over television, radio, or the
internet; and (2) any seminar or meeting whose attendees have been invited by any general solicitation or general
advertising; nor has it seen or been aware of any activity that, to its knowledge, constitutes general solicitation or
general advertising. Neither the Company nor any person acting on behalf of the Company has engaged in any “directed
selling efforts” (as defined in Regulation S) in the United States in respect of the Securities, which would include
any activities undertaken for the purpose of, or that could reasonably be expected to have the effect of, conditioning the
market in the United States for the resale of the Securities, including placing an advertisement in a publication with a
general circulation in the United States, nor has it seen or been aware of any activity that, to its knowledge, constitutes
directed selling efforts in the United States.

 

    	 	5	 

     

    

 

4.            Legends

 

4.1.            Legend. The Company will issue the Units, the Warrants and the Unit Shares, and when issued, the Warrant Shares, as the
case may be, purchased by the Purchaser, in the name of the Purchaser. Unless counsel to the Company advises otherwise, the Securities
will bear the following Legend and appropriate “stop transfer” instructions:

 

“THE
SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”),
OR ANY STATE SECURITIES LAWS AND NEITHER THE SECURITIES NOR ANY INTEREST THEREIN MAY BE OFFERED, SOLD, TRANSFERRED, PLEDGED OR
OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN EXEMPTION
FROM REGISTRATION THEREUNDER, IN EACH CASE IN ACCORDANCE WITH ALL APPLICABLE SECURITIES LAWS OF THE STATES OR OTHER JURISDICTIONS,
AND IN THE CASE OF A TRANSACTION EXEMPT FROM REGISTRATION, SUCH SECURITIES MAY ONLY BE TRANSFERRED IF THE COMPANY AND TRANSFER
AGENT FOR SUCH SECURITIES HAS RECEIVED DOCUMENTATION SATISFACTORY TO IT THAT SUCH TRANSACTION DOES NOT REQUIRE REGISTRATION UNDER
THE SECURITIES ACT.”

 

“THE
SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO AN AGREEMENT BETWEEN BISON CAPITAL ACQUISITION CORP. AND BISON CAPITAL
HOLDING COMPANY LIMITED AND MAY ONLY BE OFFERED, SOLD, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED DURING THE TERM OF THE LOCKUP
PURSUANT TO THE TERMS SET FORTH THEREIN.”

 

4.2.            Purchaser’s
Compliance. Nothing in this Section 4 shall affect in any way the Purchaser’s obligations and agreements to comply
with all applicable securities laws upon resale of the Securities.

 

4.3.            Company’s Refusal to Register Transfer of the Securities. The Company shall refuse to register any transfer of the
Securities, if in the sole judgment of the Company such purported transfer would not be made (i) pursuant to an effective
registration statement filed under the Securities Act, or (ii) pursuant to an available exemption from the registration requirements
of the Securities Act and the rules promulgated by the Commission thereunder and with all applicable state securities laws.

 

4.4.            Registration Rights. The Purchaser will be entitled to certain registration rights which will be governed by a registration
rights agreement (the “Registration Rights Agreement”) to be entered into with the Company on or prior to the
closing of the IPO.

 

5.            Lock-up

 

The
Purchaser acknowledges and agrees that the Units, the Warrants and the Unit Shares shall not be transferable, saleable or assignable
until after the consummation of a Business Combination, except to permitted transferees (as permitted in the Share Escrow Agreement
to be entered into by and between an escrow agent and the Purchaser).

 

6.            Securities Laws Restrictions

 

In
addition to any restrictions contained herein, the Purchaser agrees not to sell, transfer, pledge, hypothecate or otherwise dispose
of all or any part of the Securities unless, prior thereto (i) a registration statement on the appropriate form under the Securities
Act and applicable state securities laws with respect to the Securities proposed to be transferred shall then be effective, or
(ii) that an exempt from registration is available under the Securities Act and the rules promulgated by the Commission thereunder
and the transfer is made in accordance with all applicable state securities laws.

 

7.            Waiver of Distributions from Trust Account

 

In
connection with the Securities purchased pursuant to this Agreement, the Purchaser hereby waives any and all right, title, interest
or claim of any kind in or to any distributions from the Trust Account.

 

    	 	6	 

     

    

 

8.            Rescission Right Waiver and Indemnification

 

8.1.            Rescission
Waiver. The Purchaser understands and acknowledges that an exemption from the registration requirements of the Securities
Act requires there be no general solicitation of purchasers of the Units. In this regard, if the Offering were deemed to be a
general solicitation with respect to the Units, the offer and sale of such Units may not be exempt from registration and, if not,
the Purchaser may have a right to rescind its purchase of the Units. In order to facilitate the completion of the Offering and
in order to protect the Company, its shareholders and the Trust Account from claims that may adversely affect the Company or the
interests of its shareholders, the Purchaser hereby agrees to waive, to the maximum extent permitted by applicable law, any claims,
right to sue or rights in law or arbitration, as the case may be, to seek rescission of its purchase of the Units as a result
of the issuance of the Units being deemed to be in violation of Section 5 of the Securities Act. The Purchaser acknowledges and
agrees this waiver is being made in order to induce the Company to sell the Units to the Purchaser. The Purchaser agrees the foregoing
waiver of rescission rights shall apply to any and all known or unknown actions, causes of action, suits, claims or proceedings
(collectively, “Claims”) and related losses, costs, penalties, fees, liabilities and damages, whether
compensatory, consequential or exemplary, and expenses in connection therewith, including reasonable attorneys’ and expert
witness fees and disbursements and all other expenses reasonably incurred in investigating, preparing or defending against any
Claims, whether pending or threatened, in connection with any present or future actual or asserted right to rescind the purchase
of the Units hereunder or relating to the purchase of the Units and the transactions contemplated hereby.

 

8.2.            No Recourse Against Trust Account. The Purchaser agrees not to seek recourse against the Trust Account for any reason whatsoever
in connection with its purchase of the Units or any Claim that may arise now or in the future relating to the purchase of the
Units and the transactions contemplated hereby.

 

8.3.            Section 8 Waiver. The Purchaser agrees that to the extent any waiver of rights under this Section 8 is ineffective as a
matter of law, the Purchaser has offered such waiver for the benefit of the Company as an equitable right that shall survive any
statutory disqualification or bar that applies to a legal right. The Purchaser acknowledges the receipt and sufficiency of consideration
received from the Company hereunder in this regard.

 

9.            Terms of the Units

 

The
Units shall be substantially identical to the units offered in the IPO as set forth in an underwriting agreement to be entered
into by and between the Company and EarlyBirdCapital, Inc., except as provided for herein, and principally, (i) the Units will
be subject to the transfer restrictions described herein, (ii) the Units are being purchased pursuant to an exemption from
the registration requirements of the Securities Act and will become freely tradable only after certain conditions are met or the
resale of the Units is registered under the Securities Act, and (iii) the Warrants will be non-redeemable and may be exercised
on a cashless basis, in each case so long as they continue to be held by the initial Purchaser or its permitted transferees as
set forth in the Warrant Agreement. The Purchaser is also agreeing to certain obligations with respect to the Units as set forth
in that certain insider letter to be entered into in connection with the IPO.

 

10.          Governing Law; Jurisdiction; Waiver of Jury Trial

 

This
Agreement shall be governed by and construed in accordance with the laws of the British Virgin Islands for agreements made and
to be wholly performed within such territory. The parties hereto hereby waive any right to a jury trial in connection with any
litigation pursuant to this Agreement and the transactions contemplated hereby.

 

11.          Assignment; Entire Agreement; Amendment

 

11.1.          Assignment. Neither this Agreement nor any rights hereunder may be assigned by any party to any other person other than
by the Purchaser, without the prior consent of the Company, to one or more persons agreeing to be bound by the terms hereof. Upon
such assignment by a Purchaser, the assignee(s) shall become Purchaser hereunder and have the rights and obligations provided
for herein to the extent of such assignment.

 

    	 	7	 

     

    

 

11.2.          Entire Agreement. This Agreement sets forth the entire agreement and understanding between the parties as to the subject
matter hereof and supersedes any and all prior discussions, agreements and understandings of any and every nature.

 

11.3.          Amendment. Except as expressly provided in this Agreement, neither this Agreement nor any term hereof may be amended, waived,
discharged or terminated other than by a written instrument signed by the party against whom enforcement of any such amendment,
waiver, discharge or termination is sought.

 

11.4.          Binding
upon Successors. This Agreement shall be binding upon and inure to the benefit of the parties hereto and to their respective
heirs, legal representatives, successors and permitted assigns.

 

12.          Notices; Indemnity

 

12.1.          Notices. All notices, requests, consents and other communications hereunder shall be in writing, shall be addressed to
the receiving party’s address set forth herein or to such other address as a party may designate by notice hereunder, and
shall be either (a) delivered by hand, (b) sent by overnight courier, (c) sent via facsimile, or (d) sent by certified mail, return
receipt requested, postage prepaid. All notices, requests, consents and other communications hereunder shall be deemed to have
been given either (i) if by hand, at the time of the delivery thereof to the receiving party at the address of such party set
forth above, (ii) if sent by overnight courier, on the next business day following the day such notice is delivered to the courier
service, (iii) if sent via facsimile, when receipt is acknowledged, or (iv) if sent by certified mail, on the fifth business day
following the day such mailing is made.

 

12.2.          Indemnification. Each party shall indemnify the other party against any loss, cost or damages (including reasonable attorney’s
fees and expenses) incurred as a result of such party’s breach of any representation, warranty, covenant or agreement set
forth in this Agreement.

 

13.          Counterparts

 

This
Agreement may be executed in one or more counterparts, all of which when taken together shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood
that both parties need not sign the same counterpart.  In the event that any signature is delivered by facsimile transmission
or any other form of electronic delivery, such signature shall create a valid and binding obligation of the party executing (or
on whose behalf such signature is executed) with the same force and effect as if such signature page were an original thereof.

 

14.          Survival; Severability

 

14.1.          Survival. The representations, warranties, covenants and agreements of the parties hereto shall survive the Closing until
one (1) year following the consummation of an initial Business Combination.

 

14.2.          Severability. In the event that any provision of this Agreement becomes or is declared by a court of competent jurisdiction
to be illegal, unenforceable or void, this Agreement shall continue in full force and effect without said provision; provided that
no such severability shall be effective if it materially changes the economic benefit of this Agreement to any party.

 

15.          Headings

 

The
titles and subtitles used in this Agreement are used for convenience only and are not to be considered in construing or interpreting
this Agreement.

 

    	 	8	 

     

    

 

16.          Construction

 

The
parties hereto have participated jointly in the negotiation and drafting of this Agreement. If an ambiguity or question of intent
or interpretation arises, this Agreement will be construed as if drafted jointly by the parties hereto and no presumption or burden
of proof will arise favoring or disfavoring any party hereto because of the authorship of any provision of this Agreement. The
words “include,” “includes,” and “including” will be deemed to be followed by “without
limitation.” Pronouns in masculine, feminine, and neuter genders will be construed to include any other gender, and words
in the singular form will be construed to include the plural and vice versa, unless the context otherwise requires. The words
“this Agreement,” “herein,” “hereof,” “hereby,” “hereunder,” and words
of similar import refer to this Agreement as a whole and not to any particular subdivision unless expressly so limited. The parties
hereto intend that each representation, warranty, and covenant contained herein will have independent significance. If any party
hereto has breached any representation, warranty, or covenant contained herein in any respect, the fact that there exists another
representation, warranty or covenant relating to the same subject matter (regardless of the relative levels of specificity) which
such party hereto has not breached will not detract from or mitigate the fact that such party hereto is in breach of the first
representation, warranty, or covenant.

 

[Intentionally
Left Blank]

 

    	 	9	 

     

    

 

This
subscription is accepted by the Company as of the date first written above.

 

	 	BISON CAPITAL ACQUISITION CORP.
	 	 	 
	 	By:	/s/ James Jiayuan Tong
	 	 	Name: James Jiayuan Tong
	 	 	Title: Chief Executive Officer, Chief Financial Officer and Director

 

[Signature Page to Private Units Subscription Agreement-the
Company]

     

     

    

 

Accepted
and agreed this

20th
 day of December 2016

 

	BISON CAPITAL HOLDING COMPANY LIMITED	 
	 	 	 
	By:	/s/ Peixin Xu	 
	 	Name: Peixin Xu	 
	 	Title: Director	 

 

 

[Signature Page to Private Units Subscription Agreement-Bison
Capital]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00271-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00271-of-00352.parquet"}]]